PERRIGO Co plc (PRGO)
As of Sep 20, 2026, PERRIGO Co plc (PRGO) scores 5.1/10 on AlphaStocks' five-model composite, #104 of 168 Health Care stocks.
Health Care / Pharmaceuticals
S&P SmallCap 600$13.59
Below average on several measures. Research carefully.
Consider Buy
Score based on 4 of 5 models — moderate confidence
Data as of Sep 20, 2026
Is PERRIGO Co plc a Good Investment in 2026?
PERRIGO Co plc (PRGO) scores 5.1 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model is the most favorable, rating PERRIGO Co plc as Neutral. However, the Greenblatt Magic Formula model rates it Caution — Earnings yield -24.8% · ROC -42%. PERRIGO Co plc ranks #104 out of 168 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Currently unprofitable — fair value estimate not available.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Neutral
4/9
Buffett
Caution
Business quality & competitive moat
Graham
Neutral
Price vs intrinsic value
Lynch
Neutral
Growth rate vs price (PEG)
Greenblatt
Caution
Earnings yield -24.8% · ROC -42%
Frequently Asked Questions
Is PERRIGO Co plc (PRGO) a good investment?
What is PERRIGO Co plc's Piotroski F-Score?
Is PRGO overvalued or undervalued?
How does PRGO compare to other Health Care stocks?
What do investment models say about PRGO?
Similar Stocks
Compare PRGO with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer